Somite AI Raises $47M Series A to revolutionize Cell Therapy
Somite AI Raises $47M Series A to revolutionize Cell Therapy
Other news
Ajinomoto Group Ventures invests in optogenetic fermentation company Fermeate
Ajinomoto Group Ventures invests in optogenetic gene therapy company Restore Vision
Ajinomoto Group Ventures year in review